3
(Adds details throughout) Nov 6 (Reuters) – Dental health company vVardis said on Friday it was targeting a valuation of up to $4.37 billion in its US initial public offering, seeking to capitalize on
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)